An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.
about
An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@en
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@nl
type
label
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@en
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@nl
prefLabel
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@en
An innovative immunotherapeuti ...... 10A and glycomimetic peptides.
@nl
P2093
P2860
P1476
An innovative immunotherapeuti ...... C10A and glycomimetic peptides
@en
P2093
Katherine F Roby
Laura L Eggink
Robert Cote
P2860
P2888
P356
10.1186/S40425-018-0339-5
P577
2018-04-17T00:00:00Z
P6179
1103413850